| Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets F Newell, Y Kong, JS Wilmott, PA Johansson, PM Ferguson, C Cui, Z Li, ... Nature communications 10 (1), 3163, 2019 | 275 | 2019 |
| Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities R Rabbie, P Ferguson, C Molina‐Aguilar, DJ Adams, ... The Journal of pathology 247 (5), 539-551, 2019 | 244 | 2019 |
| Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation EC Paver, WA Cooper, AJ Colebatch, PM Ferguson, SK Hill, T Lum, ... Pathology 53 (2), 141-156, 2021 | 207 | 2021 |
| Simple synthesis and functionalization of iron nanoparticles for magnetic resonance imaging S Cheong, P Ferguson, KW Feindel, IF Hermans, PT Callaghan, C Meyer, ... Angewandte Chemie 123 (18), 4292-4295, 2011 | 194 | 2011 |
| Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma MT Tetzlaff, JL Messina, JE Stein, X Xu, RN Amaria, CU Blank, ... Annals of Oncology 29 (8), 1861-1868, 2018 | 190 | 2018 |
| ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms T Bouchery, R Kyle, M Camberis, A Shepherd, K Filbey, A Smith, M Harvie, ... Nature communications 6 (1), 6970, 2015 | 182 | 2015 |
| Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial GV Long, RPM Saw, S Lo, OE Nieweg, KF Shannon, M Gonzalez, ... The Lancet Oncology 20 (7), 961-971, 2019 | 171 | 2019 |
| Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity F Newell, JS Wilmott, PA Johansson, K Nones, V Addala, ... Nature communications 11 (1), 5259, 2020 | 138 | 2020 |
| Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance F Newell, IP da Silva, PA Johansson, AM Menzies, JS Wilmott, V Addala, ... Cancer cell 40 (1), 88-102. e7, 2022 | 103 | 2022 |
| Melanoma pathology reporting and staging RA Scolyer, RV Rawson, JE Gershenwald, PM Ferguson, VG Prieto Modern Pathology 33, 15-24, 2020 | 101 | 2020 |
| A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy RJ Anderson, C Tang, NJ Daniels, BJ Compton, CM Hayman, ... Nature chemical biology 10 (11), 943-949, 2014 | 94 | 2014 |
| Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients H Lee, C Quek, I Silva, A Tasker, M Batten, H Rizos, SY Lim, T Nur Gide, ... Oncoimmunology 8 (2), e1537581, 2019 | 84 | 2019 |
| Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T 2 contrast enhancement in magnetic resonance imaging DAJ Herman, P Ferguson, S Cheong, IF Hermans, BJ Ruck, KM Allan, ... Chemical communications 47 (32), 9221-9223, 2011 | 74 | 2011 |
| Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer AM Hong, P Ferguson, T Dodds, D Jones, M Li, J Yang, RA Scolyer Oral oncology 92, 33-39, 2019 | 67 | 2019 |
| Molecular Genomic Profiling of Melanocytic Nevi AJ Colebatch, P Ferguson, F Newell, SH Kazakoff, T Witkowski, ... Journal of Investigative Dermatology 139 (8), 1762-1768, 2019 | 65 | 2019 |
| Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility JS Wilmott, PA Johansson, F Newell, N Waddell, P Ferguson, C Quek, ... International journal of cancer 144 (5), 1049-1060, 2019 | 59 | 2019 |
| Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma MK Hunn, KJ Farrand, KWR Broadley, R Weinkove, P Ferguson, RJ Miller, ... Clinical Cancer Research 18 (23), 6446-6459, 2012 | 57 | 2012 |
| HDAC inhibitors restore BRAF‐inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma SJ Gallagher, D Gunatilake, KA Beaumont, DM Sharp, JC Tiffen, ... International journal of cancer 142 (9), 1926-1937, 2018 | 49 | 2018 |
| Synthesis and stability of highly crystalline and stable iron/iron oxide core/shell nanoparticles for biomedical applications S Cheong, P Ferguson, IF Hermans, GNL Jameson, S Prabakar, ... ChemPlusChem 77 (2), 135-140, 2012 | 47 | 2012 |
| Comparative genomics provides etiologic and biological insight into melanoma subtypes F Newell, PA Johansson, JS Wilmott, K Nones, V Lakis, AL Pritchard, ... Cancer discovery 12 (12), 2856-2879, 2022 | 44 | 2022 |
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalVerified email at sswahs.nsw.gov.au
